Is pharmaceutical R

Author： Schmid E.F.   Smith D.A.  

Publisher： Elsevier

ISSN： 1359-6446

Source： Drug Discovery Today, Vol.9, Iss.1, 2004-01, pp. : 18-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Considering the economic principles of pharmaceutical R&D

By Vernon John A  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 21-22

Informa Healthcare

Access to resources Recommend Favorite

Key issues in the pharmaceutical industry: consequences on R&D

By Malik Nafees N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Measuring US Pharmaceutical Industry R&D Spending

By Golec Joseph   Vernon John  

PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. : 1005-1017

Adis International

Access to resources Recommend Favorite

A Review of: “Pharmaceutical Statistics Using SAS: A Practical Guide, by A. Dmitrienko, C. Chuang-Stein, and R. B. D'Agostino (eds.)”

By Mietlowski William  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 3, 2008-05 ,pp. : 590-594

Taylor & Francis Ltd

Access to resources Recommend Favorite

A HPLC validated assay of paclitaxel's related impurities in pharmaceutical forms containing Cremophor ( R) EL

By Ciutaru D.   Badea I.   Lazar L.   Nicolescu D.   Tudose A.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 34, Iss. 3, 2004-02 ,pp. : 493-499

Elsevier

Access to resources Recommend Favorite